Skip to main content
Log in

Adiponectin and leptin gene polymorphisms in women with gestational diabetes mellitus

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Gestational diabetes mellitus (GDM) is the glucose intolerance occurring during pregnancy. The prevalence of GDM is increased in obese women. Leptin and adiponectin are adipokines that play an important role in the regulation of insulin secretion and glucose and lipid metabolism. The aim of this study was to examine the association between adiponectin and leptin gene polymorphisms and the development of GDM.

Methods

This case–control study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). The diagnosis of GDM was based on a 75-g oral glucose tolerance test (OGTT) at 24–28 weeks’ gestation. To discriminate the ADIPOQ rs266729, rs1501299 and LEP rs2167270 alleles, TaqMan® Pre-Designed SNP Genotyping Assays were used.

Results

There was a statistically significant association between the ADIPOQ rs266729 gene polymorphism and GDM. Among women with GDM, a higher prevalence of the G allele was observed (GG and CG genotypes). Multivariate logistic regression analysis, taking into account age, BMI before pregnancy, past pregnancies and the ADIPOQ rs266729 gene polymorphism, revealed that the presence of a G allele is an independent risk factor for GDM. Moreover, there was the association between the LEP rs2167270 polymorphism and the requirement for daily insulin, which was significantly higher in women with the A allele (AA and GA genotypes).

Conclusions

The results of our study suggest an association between adiponectin gene rs266729 as well as leptin gene rs2167270 polymorphisms and GDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kim C. Gestational diabetes: risks, management, and treatment options. Int J Womens Health. 2010;2:339–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30:112–9.

    Article  Google Scholar 

  3. Carbillon L, Boujenah J, Benbara A, Cosson E. Adverse outcomes and potential targets for intervention in gestational diabetes and obesity. Obstet Gynecol. 2015;126:1309–10.

    Article  PubMed  Google Scholar 

  4. Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, Martínez JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism. 2015;64:35–46.

    Article  PubMed  Google Scholar 

  5. Martin SS, Blaha MJ, Muse ED, Qasim AN, Reilly MP, Blumenthal RS, et al. Leptin and incident cardiovascular disease: the Multi-ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2015;239:67–72.

    Article  CAS  PubMed  Google Scholar 

  6. Al-Azzam SI, Khabour OF, Alzoubi KH, Alzayadeen RN. The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors. J Endocrinol Invest. 2014;37:835–42.

    Article  CAS  PubMed  Google Scholar 

  7. Kadowaki T, Yamauchi T, Okada-Iwabu M, Iwabu M. Adiponectin and its receptors: implications for obesity-associated diseases and longevity. Lancet Diabetes Endocrinol. 2014;2:8–9.

    Article  PubMed  Google Scholar 

  8. Jung CH, Kim BY, Mok JO, Kang SK, Kim CH. Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus. J Diabetes Investig. 2014;5:333–9.

    Article  CAS  PubMed  Google Scholar 

  9. Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO, et al. Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J Diabetes Investig. 2014;5:192–8.

    Article  CAS  PubMed  Google Scholar 

  10. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.

    Article  PubMed Central  Google Scholar 

  11. Teler J, Tarnowski M, Safranow K, Maciejewska A, Sawczuk M, Dziedziejko V et al. CCL2, CCL5, IL4 and IL15 gene polymorphisms in women with gestational diabetes mellitus. Horm Metab Res. 2016, doi:10.1055/s-0042-111436.

  12. Lin CH, Ho CY, Liu CS, Lin WY, Li CI, Yang CW, et al. Influence of adiponectin gene polymorphisms on adiponectin serum level and insulin resistance index in taiwanese metabolic syndrome patients. Chin J Physiol. 2012;55:405–11.

    Article  CAS  PubMed  Google Scholar 

  13. Petrone A, Zavarella S, Caiazzo A, Leto G, Spoletini M, Potenziani S, et al. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity (Silver Spring). 2006;14:1498–504.

    Article  CAS  Google Scholar 

  14. Tankó LB, Siddiq A, Lecoeur C, Larsen PJ, Christiansen C, Walley A, et al. ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes Res. 2005;13:2113–21.

    Article  PubMed  Google Scholar 

  15. Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol. 2010;325:78–83.

    Article  CAS  PubMed  Google Scholar 

  16. Sahin DS, Tumer C, Demir C, Celik MM, Celik M, Ucar E, et al. Association with leptin gene C.-2548 G > A polymorphism, serum leptin levels, and body mass index in Turkish obese patients. Cell Biochem Biophys. 2013;65:243–7.

    Article  CAS  PubMed  Google Scholar 

  17. Mammès O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet. 2000;64:391–4.

    Article  PubMed  Google Scholar 

  18. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia. 2005;48:993–1001.

    Article  CAS  PubMed  Google Scholar 

  19. Desoye G, Hauguel-de MS. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30:120–6.

    Article  Google Scholar 

  20. Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S, García-Caballero T, et al. Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab. 2005;90:4276–86.

    Article  CAS  PubMed  Google Scholar 

  21. Doruk M, Uğur M, Oruç AS, Demirel N, Yildiz Y. Serum adiponectin in gestational diabetes and its relation to pregnancy outcome. J Obstet Gynaecol. 2014;34:471–5.

    Article  CAS  PubMed  Google Scholar 

  22. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49:1677–85.

    Article  CAS  PubMed  Google Scholar 

  23. Hara K, Yamauchi T, Kadowaki T. Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans. Curr Diab Rep. 2005;5:136–40.

    Article  CAS  PubMed  Google Scholar 

  24. Lam NT, Cheung AT, Riedel MJ, Light PE, Cheeseman CI, Kieffer TJ. Leptin reduces glucose transport and cellular ATP levels in INS-1 beta-cells. J Mol Endocrinol. 2004;32:415–24.

    Article  CAS  PubMed  Google Scholar 

  25. Lee JW, Swick AG, Romsos DR. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway. Exp Biol Med (Maywood). 2003;228:175–82.

    Article  CAS  Google Scholar 

  26. Soheilykhah S, Mojibian M, Rahimi-Saghand S, Rashidi M, Hadinedoushan H. Maternal serum leptin concentration in gestational diabetes. Taiwan J Obstet Gynecol. 2011;50:149–53.

    Article  PubMed  Google Scholar 

  27. Pérez-Pérez A, Guadix P, Maymó J, Dueñas JL, Varone C, Fernández-Sánchez M, et al. Insulin and leptin signaling in placenta from gestational diabetic subjects. Horm Metab Res. 2016;48:62–9.

    PubMed  Google Scholar 

  28. Beltcheva O, Boyadzhieva M, Angelova O, Mitev V, Kaneva R, Atanasova I. The rs266729 single-nucleotide polymorphism in the adiponectin gene shows association with gestational diabetes. Arch Gynecol Obstet. 2014;289:743–8.

    Article  CAS  PubMed  Google Scholar 

  29. Han Y, Zheng YL, Fan YP, Liu MH, Lu XY, Tao Q. Association of adiponectin gene polymorphism 45TG with gestational diabetes mellitus diagnosed on the new IADPSG criteria, plasma adiponectin levels and adverse pregnancy outcomes. Clin Exp Med. 2015;15:47–53.

    Article  CAS  PubMed  Google Scholar 

  30. Takhshid MA, Haem Z, Aboualizadeh F. The association of circulating adiponectin and +45 T/G polymorphism of adiponectin gene with gestational diabetes mellitus in Iranian population. J Diabetes Metab Disord. 2015;14:30.

  31. Low CF, Mohd Tohit ER, Chong PP, Idris F. Adiponectin SNP45TG is associated with gestational diabetes mellitus. Arch Gynecol Obstet. 2011;283:1255–60.

    Article  CAS  PubMed  Google Scholar 

  32. Vaskú JA, Vaskú A, Dostálová Z, Bienert P. Association of leptin genetic polymorphism −2548 G/A with gestational diabetes mellitus. Genes Nutr. 2006;1:117–23.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 2002;34:355–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrzej Pawlik.

Ethics declarations

The study was approved by the ethics committee in Pomeranian Medical University, Szczecin, Poland, and written informed consent was obtained from all subjects.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Capsule

This study examined the association between adiponectin and leptin gene polymorphisms and the development of GDM.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pawlik, A., Teler, J., Maciejewska, A. et al. Adiponectin and leptin gene polymorphisms in women with gestational diabetes mellitus. J Assist Reprod Genet 34, 511–516 (2017). https://doi.org/10.1007/s10815-016-0866-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-016-0866-2

Keywords

Navigation